Communicating a Cancer Diagnosis-Current Methods and Their Effects
|ClinicalTrials.gov Identifier: NCT00674804|
Recruitment Status : Completed
First Posted : May 8, 2008
Last Update Posted : July 2, 2017
This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:
- Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
- Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
- Identify who informs the patient of their diagnosis..
- Determine patient satisfaction with their diagnostic consult.
- Identify indicators of satisfaction with the diagnostic consultation.
Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.
Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
|Condition or disease|
- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs.
To distinguish, identify and determine:
- If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed
- Who tells the patient of their condition
- The methods used to inform a patient of their condition
- Prognostic indicators of high satisfaction within the diagnostic consult
- Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.
- Patient must be 18 years or older and be willing to participate in the study.
- Primary methodological practice is a self-administered questionnaire.
- Questionnaire to be completed by patient on same day that it is administered at NCI.
|Study Type :||Observational|
|Estimated Enrollment :||1100 participants|
|Official Title:||Communicating a Cancer Diagnosis: Current Methods and Their Effects|
|Study Start Date :||April 24, 2008|
|Primary Completion Date :||July 16, 2009|
|Study Completion Date :||July 16, 2009|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00674804
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|